|
ABOUT COMPANY
Esperion Therapeutics, Inc., a pharmaceutical company, develops and markets drugs for the treatment of patients with high low-density lipoprotein cholesterol in the United States and internationally. The company is headquartered in Ann Arbor, Michigan.
|
EARNINGS
Gross Profit (TTM): 78219000
Market Capitalization: 311575000
Operating Margin (TTM): -3.487
PE Ratio: None
PEG Ratio: -4.78
Profit Margin: 0
Revenue Per Share (TTM): 2.754
Revenue (TTM): 72684000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 2.759
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -11.69
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -79313000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|